Ambrilia Biopharma


Ambrilia Biopharma Inc. is a biotechnology company focused on the discovery and development of novel treatments for viral diseases and cancer. The Company's strategy aims to capitalize on its broad portfolio and original expertise in virology. Ambrilia's product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a therapeutic peptide for prostate cancer, a targeted delivery technology for cancer, HIV protease, in...Show all

Ambrilia Biopharma Inc. is a biotechnology company focused on the discovery and development of novel treatments for viral diseases and cancer. The Company's strategy aims to capitalize on its broad portfolio and original expertise in virology. Am...Show all

Company (Alive / Active)

Phone:

Fax:

Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Ambrilia Biopharma $0M Nov 30, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Ambrilia Biopharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
BDC Venture CapitalVenture CapitalMontreal, Quebec, CanadaOther Investors
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Derivatives of pyridoxine for inhibiting hiv integrase Jan 11, 2011 Oct 09, 2012 Patent
Psp94 diagnostic reagents and assays Jun 17, 2005 May 19, 2009 Patent